Schedule 13D ownership disclosure

Organogenesis Holdings Inc

Class A Common Stock, par value $0.0001 per share · CUSIP: 68621F102

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Alan A. AdesReported CIK 0001757286

    Shares: 22,319,837 · Class: 17.8%

  • Albert Erani

    Shares: 17,920,498 · Class: 14.3%

  • Glenn H. Nussdorf

    Shares: 11,912,841 · Class: 9.5%

  • Dennis Erani

    Shares: 10,043,701 · Class: 8%

  • Starr Wisdom

    Shares: 20,000 · Class: 0%

  • Organo PFG LLC

    Shares: 8,279,490 · Class: 6.6%

  • Organo Investors LLC

    Shares: 2,851,984 · Class: 2.3%

  • Alan Ades 2014 GRAT

    Shares: 3,075,865 · Class: 2.4%

  • Albert Erani Family Trust dated 12/29/2012

    Shares: 0 · Class: 0%

  • Dennis Erani 2012 Issue Trust dated 12/20/12

    Shares: 8,382,031 · Class: 6.7%

  • GN 2016 Family Trust u/a/d August 12, 2016

    Shares: 918,680 · Class: 0.7%

  • GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016

    Shares: 8,871,320 · Class: 7.1%

  • RED Holdings, LLC

    Shares: 6,784,024 · Class: 5.4%

  • Josette Ades

    Shares: 1,710,552 · Class: 1.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-001352
Form type
SCHEDULE 13D/A
Filer
Ades Alan A.
CIK
CIK 1757286
Filed
Jan 03, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub